title: Structure, function, and pharmacology of NMDA receptor channels.
abstract: NMDA receptors have received much attention over the last few decades, due to their role in many types of neural plasticity on the one hand, and their involvement in excitotoxicity on the other hand. There is great interest in developing clinically relevant NMDA receptor antagonists that would block excitotoxic NMDA receptor activation, without interfering with NMDA receptor function needed for normal synaptic transmission and plasticity. This review summarizes current understanding of the structure of NMDA receptors and the mechanisms of NMDA receptor activation and modulation, with special attention given to data describing the properties of various types of NMDA receptor inhibition. Our recent analyses point to certain neurosteroids as NMDA receptor inhibitors with desirable properties. Specifically, these compounds show use-dependent but voltage-independent block, that is predicted to preferentially target excessive tonic NMDA receptor activation. Importantly, neurosteroids are also characterized by use-independent unblock, compatible with minimal disruption of normal synaptic transmission. Thus, neurosteroids are a promising class of NMDA receptor modulators that may lead to the development of neuroprotective drugs with optimal therapeutic profiles.
authors.affiliation: Department of Cellular Neurophysiology, Institute of Physiology Academy of Sciences of the Czech Republic, Prague, Czech Republic. vyklicky@biomed.cas.cz.
authors.forename: V
authors.initials: V
authors.lastname: Vyklicky
authors.forename: M
authors.initials: M
authors.lastname: Korinek
authors.forename: T
authors.initials: T
authors.lastname: Smejkalova
authors.forename: A
authors.initials: A
authors.lastname: Balik
authors.forename: B
authors.initials: B
authors.lastname: Krausova
authors.forename: M
authors.initials: M
authors.lastname: Kaniakova
authors.forename: K
authors.initials: K
authors.lastname: Lichnerova
authors.forename: J
authors.initials: J
authors.lastname: Cerny
authors.forename: J
authors.initials: J
authors.lastname: Krusek
authors.forename: I
authors.initials: I
authors.lastname: Dittert
authors.forename: M
authors.initials: M
authors.lastname: Horak
authors.forename: L
authors.initials: L
authors.lastname: Vyklicky
mesh_terms: D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D001927:Brain Diseases / Q000188:drug therapy* / Q000378:metabolism*; D006801:Humans; D015640:Ion Channel Gating / Q000187:drug effects; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D011487:Protein Conformation; D016194:Receptors, N-Methyl-D-Aspartate / Q000737:chemistry* / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D013329:Structure-Activity Relationship; D009435:Synaptic Transmission / Q000187:drug effects*
chemical_list: D018696:Neuroprotective Agents; D016194:Receptors, N-Methyl-D-Aspartate